Patent details

EP2902035 Title: Cell-permeable peptide inhibitors of the JNK signal transduction pathway for use in the treatment of inflammatory eye diseases.

Basic Information

Publication number:
EP2902035
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP140044272
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Cell-permeable peptide inhibitors of the JNK signal transduction pathway for use in the treatment of inflammatory eye diseases.
French Title of Invention:
D'inhibiteurs de peptidiques perméables aux cellules de la voie de transduction de signal JNK pour l'utilisation dans le traitement des maladies oculaires inflammatoires
German Title of Invention:
Zelldurchlässiger Peptidhemmer des JNK-Signaltransduktionsweges zur Verwendung in der Behandlung von Entzündungserkrankungen des Auges
SPC Number:

Dates

Filing date:
14/10/2011
Grant date:
20/06/2018
EP Publication Date:
05/08/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/06/2018
EP B1 Publication Date:
20/06/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
14/10/2018
Expiration date:
14/10/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/06/2018
 
 

Name:
Xigen Inflammation Ltd.
Address:
Arch. Makariou III 195 Neocleous House, 3030 Limassol, Cyprus (CY)

Inventor

1

Name:
Abadie, Claire
Address:
France (FR)

2

Name:
Combette, Jean-Marc
Address:
France (FR)

3

Name:
Deloche, Catherine
Address:
Switzerland (CH)

Priority

1

Priority Number:
PCT/EP2010/006284
Priority Date:
14/10/2010
Priority Country:
World Intellectual Property Office (WIPO) (WO)

2

Priority Number:
PCT/EP2011/000307
Priority Date:
25/01/2011
Priority Country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC classification:
A61K 38/00; A61K 38/03; A61K 38/04; A61P 27/02;

Publication

European Patent Bulletin

Issue number:
201825
Publication date:
20/06/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
28/02/2019 Outgoing Correspondence 1